This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related article  • Related letter  • Similar articles in this journal  Topic Collections  • Alzheimer Disease  • Dementias  • Drug Therapy  • Drug Therapy, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

Noa Bregman, MD; Arnon Karni, MD; Amos D. Korczyn, MD, MSc

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT) results published recently in the Archives¹ attempt to add data on the potential effect of nonsteroidal anti-inflammatory drugs (NSAIDs) in preventing the development of Alzheimer disease (AD). Unfortunately, the untimely termination of the study limits the conclusions that can be drawn.

The hypothesis leading to this expensive study is not formulated in the article, but presumably it was that NSAIDs will reduce the incidence of AD. Therefore, an implicit assumption has been that there will be a number of subjects who will convert to dementia over the observation period. We are not told whether any subjects have actually converted as the data only convey mean results on cognitive tests. Moreover, it seems that no tests showed significant reductions in cognitive scores in the control group. If this is so, one cannot test . . . [Full Text of this Article]

AUTHOR INFORMATION



CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Cognitive Function Over Time in the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT): Results of a Randomized, Controlled Trial of Naproxen and Celecoxib
ADAPT Research Group
Arch Neurol. 2008;65(7):896-905.
ABSTRACT | FULL TEXT  

RELATED LETTER

Can Treatment With Nonsteroidal Anti-inflammatory Drugs Protect From Dementia?—Reply
Barbara K. Martin, Jason Brandt, John C. S. Breitner, Suzanne Craft, Denis Evans, Robert Green, Michael Mullan, Steven Piantadosi, and Christine Szekely
Arch Neurol. 2009;66(4):540.
EXTRACT | FULL TEXT